Is the FDA COVERING UP Testosterone Dangers?!

Well, looks like they’ve done it again.

The FDA—that supposed “watchdog” agency that’s supposed to protect you—just quietly removed the boxed warning about heart attacks and strokes from testosterone products.

Yeah, like there’s no data out there re testosterone and heart attacks…

That’s right. The same warning they INSISTED on putting there in 2015 because men were dying is suddenly… gone.

And in its place? A mild warning about blood pressure.

If you’re one of the millions of men taking testosterone replacement therapy, you need to know what they’re hiding from you.

Because this isn’t about your health. It’s about PROFITS.

Let me be crystal clear:

Nothing has changed about the dangers of testosterone replacement.

The FDA is claiming this decision was based on something called the “TRAVERSE trial.” But let’s look at what they’re not telling you:

1. This study was funded by the very companies that make testosterone products!
2. It only followed men for 33 months—far too short to see the REAL long-term effects
3. It conveniently found that testosterone was “noninferior” to placebo—the bare minimum standard they needed to meet

What does “noninferior” even mean? It means they didn’t prove it was safer—just that it wasn’t worse than doing nothing!

And here’s the kicker: Even their own data still showed that 7% of men on testosterone had major cardiovascular events!

That’s seven out of every hundred men having heart attacks, strokes, or dying from cardiovascular causes!

Does that sound safe to you?

Meanwhile, the FDA quietly admits that all testosterone products increase blood pressure. Let that sink in.

We know that increased blood pressure leads to:

• Heart attacks
• Strokes
• Kidney damage
• Vision problems
• And more!

So they’re removing the warning about heart attacks while admitting the product causes the very thing that leads to heart attacks!

This is medical doublespeak at its finest, folks.

The pharmaceutical companies have been desperate to get this warning removed.

Why? Because those little black boxes on their products were scaring away customers and hurting their bottom line!

Since 2014, when the FDA first warned about these risks, Big Pharma has been scheming to get these warnings removed. And now they’ve succeeded.

What’s really happening here is clear…

• The warnings were hurting sales
• Companies funded their own study
• The FDA caved to industry pressure
• Now men will be less informed about the risks

Ask yourself: If testosterone was truly safe, why would they need to add NEW warnings about blood pressure while removing the old ones?

The answer is simple: They’re playing a shell game with your health.

Before you start—or continue—testosterone replacement therapy, ask your doctor these tough questions:

• Why is my testosterone low in the first place?
• What natural methods can I try first?
• What are the real risks to my heart and blood vessels?
• Who benefits most from me taking this drug?

Remember, there are natural ways to boost your testosterone:

• Strength training
• Getting adequate sleep
• Reducing stress
• Eating zinc-rich foods
• Vitamin D supplementation
• Losing excess weight

The medical establishment wants you to believe that every problem can be solved with a prescription. But your body was designed to heal naturally when given the right tools.

Don’t be fooled by this dangerous FDA decision. The risks of testosterone replacement haven’t magically disappeared just because they removed a warning label.

In Your Corner,

Dr. Allan Spreen

In Case You Missed It

• Scientists Just Found a Way to Starve Lung Cancer—Naturally
• Boost Recovery with This Simple Sick-Day Strategy
• The Silent Epidemic WRECKING Seniors’ Health
• The Sunscreen Mistake That’s Putting You at Risk
• A Cannabis Breakthrough for Pain—Without the High
• Antibiotic Resistance Just Got WORSE—Here’s What’s to Blame
• Dirt-Cheap Supplement Supercharges Your Brain?

Sources:

FDA Announcement, March 2025: “FDA Drops Testosterone’s Boxed Warning on Heart Attack, Stroke Risk”

TRAVERSE clinical trial results, 2025

FDA MedWatch Adverse Event Reporting program data, 2014-2025

Martinez, C., Suissa, S., Rietbrock, S., Katholing, A., Freedman, B., Cohen, A. T., & Handelsman, D. J. (2016). Testosterone treatment and risk of venous thromboembolism: Population based case-control study. BMJ, 355, i5968. https://doi.org/10.1136/bmj.i5968

Vigen, R., O’Donnell, C. I., Barón, A. E., Grunwald, G. K., Maddox, T. M., Bradley, S. M., Barqawi, A., Woning, G., Wierman, M. E., Plomondon, M. E., Rumsfeld, J. S., & Ho, P. M. (2013). Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels. JAMA, 310(17), 1829–1836. https://doi.org/10.1001/jama.2013.280386